Global Clinical Nutrition Market Size Was Worth USD 51 billion in 2020 and Is Projected to Grow to USD 73 billion by 2026, at a CAGR of 6.04% Over The Forecast Period 2021 to 2026

Global Clinical Nutrition Market Size Was Worth USD 51 billion in 2020 and Is Projected to Grow to USD 73 billion by 2026, at a CAGR of 6.04% Over The Forecast Period 2021 to 2026

November 18, 2021, New York, USA -

Clinical Nutrition: Introduction

Clinical nutrition centres on the diagnosis, prevention and management of changes in nutrition for patients suffering from chronic conditions and diseases, most often in the field of health and healthcare. Clinical nutrition is the term used to describe the treatment of patients, which includes not only outpatients in clinics and private practice but also those at hospitals. It is primarily based on the scientific areas of dietetics and nutrition. Additionally, clinical nutrition seeks to maintain a healthy and balanced energy balance while also offering adequate amounts of nutrients like vitamins, protein, and minerals for patients.

The Global Clinical Nutrition Market Forecast: 

The market for clinical nutrition was estimated at USD 51 billion by 2020. It is predicted to grow to USD 73 billion by 2026. It is expected to grow at a CAGR of 6.04 percent over the forecast time.

Clinical nutrition helps improve digestion, absorption, metabolism and discharge processes by providing vital nutrients, such as vitamins, minerals, as well as proteins. These are essential for patients suffering from the highest levels of malnutrition and patients in intensive treatment units, those recovering from surgery or trauma, as well as patients with chronic illnesses. It has been discovered that treating malnutrition due to illness by using clinical nutrition therapy can lower the risk of dying.

Clinical nutrition is essential for those suffering from nutritional deficiencies or who are unable to eat due to increased disease conditions that result in reduced health, a higher chance of developing complications, an increased risk of dying and prolonging a time to recover. Clinical nutrition plays an essential part in maintaining balanced nutrition in malnourished patients who are at an increased risk of developing complications due to a deficiency of nutrition.

Certain factors are driving the development of the clinical nutrition market, including the rising incidence of metabolic diseases as well as the huge amount of money spent on healthcare and the growth of the middle class in the new economies. In the last decade, the incidence of metabolic diseases has been increasing. Based on the Global Coalition on Aging research, November 2020, the rate of malnutrition among patients admitted to hospitals was 31%.

Based on the Global Surgery Foundation, nearly 30% of the world's illnesses can be treated by surgery, and they require the direct supervision of a surgeon. Clinical nutrition plays an important part in surgeries to limit the negative effects on patients and allow surgeons to operate in a controlled setting. Therefore, due to the increasing incidence of disease and the increasing number of operations and surgeries, the market for clinical nutrition is predicted to grow over the next few years.

Additionally, as per The World Ageing Population report, in the year 2020, 727 million people around the world were 65 years old or above. The figure is also predicted to grow to 1.5 billion by 2050. The older population is usually at risk of developing chronic illnesses that can result in surgeries.

In July 2020, Goodmills Innovation had introduced ''Spermidino EVO," A concentrate of wheat germ, which was specifically designed to boost immunity in the population of the elderly. Therefore, the increasing amount of people who are elderly and the creation of nutritional products for clinical use that are tailored to the population of the elderly are likely to drive the market's growth.

Market Trend and Dynamics of the Global Clinical Nutrition Market:

In The Route of Administration Segment, The Fastest Growth Is Expected To Have by Nutritional Support for Metabolic Disorders.   

Patients suffering from metabolic diseases like diabetes are at a higher chance of developing COVID-19. Based on the International Diabetes Federation findings, individuals who suffer from pre-existing medical issues like obesity and diabetes are more susceptible to being infected by the SARS-CoV-2 virus due to the weak immune system within these people. Furthermore, treating people with diabetes suffering from COVID-19 may prove to be challenging since the virus can increase dramatically in glucose levels. The control of the level of blood sugar is of paramount importance when dealing with COVID-19 patients. Hence nutrition plays an important role in this regard, helping to increase the size of this segment.

Additionally, the increasing burden of metabolic diseases is increasing the demand for nutritional therapy. According to the International Diabetes Federation, about 425 million people are affected by diabetes, and that number is predicted to increase to 700 million by 2045. Therefore, the rising burden of metabolic diseases and the launch of new products into the market are likely to boost this market. In addition, the increase in the launch of new products is likely to drive the growth of the market. As a result, in February 2020, Galen released an ingenious medical food product called PKU EASY Microtabs that is aimed at those suffering from the rare, genetic metabolic disorder called phenylketonuria (PKU).

In the Clinical Nutrition Market, the Majority of the Shares are held by North America. It is predicted that It is going to dominate the area over the Forecast Period. 

North America contributes heavily to the expansion of markets compared to other regions. The development of COVID-19 has resulted in a shortage of nutritional products for clinical use in this region. Based on the information supplied from the American Society for Parenteral and Enteral Nutrition (ASPEN), 23.4% of injections and certain parenteral products are currently facing a shortage. Those products include sodium chloride, multivitamin infusion (adult and paediatric), USP, amino acids, potassium acetate injection and sodium acetate injections.   

To keep up with the ever-changing demands triggered by new purchasing habits during the COVID-19 epidemic, companies have increased their production. They are also working together with the retailers and government agencies to make sure that there is continuous access to oral nutritional products.

In addition, there are a variety of reasons for the expansion of the clinical nutrition industry are an increase in the incidence of metabolic disorders as well as an increase in the number of geriatric patients. Based on the Centers for Disease Control and Prevention, the prevalence of obesity within those in the US populace was calculated at 42.4 percent in 2017-2018. According to the data provided by the Center for Disease Control and Prevention the heart and cancer illnesses are among the most significant issues facing the US health care system. According to the statistics of the American Heart Association, in the year 2017, more than 8,59,125 Americans were killed from cardiovascular disease. Therefore, these figures indicate an increase in demand for products that aid in clinical nutrition, which is stimulating the market to expand.

The Key Market Segmentation of the Global Clinical Nutrition Market: 

Global Clinical Nutrition Market can be divided into Route of Administration, End-User, Applications, and Geographical landscapes, etc. 

Clinical Nutrition Market Segmentation By Route of Administration:




Clinical Nutrition Market Segmentation By End-User: 




Clinical Nutrition Market Segmentation By Product Application:


Neurological Diseases

Gastrointestinal Disorders

Metabolic Disorders


Clinical Nutrition Market Segmentation By Geographical Landscape:

North America


Asia Pacific

South America

Middle East and Africa

Major Key Players in the Global Clinical Nutrition Market Are:

  • Abbott Nutrition
  • Nutricia
  • Perrigo Company PLC
  • Nestle Health Science
  • Baxter Healthcare
  • Braun Melsungen AG
  • Fresenius Kabi

The Covid-19 Impact Analysis:

COVID-19 has emerged as an important health concern for the public, and the role of clinical nutrition plays a vital role in preventing infections and managing malnutrition caused by infection. For instance, the European Society for Clinical Nutrition and Metabolism released guidelines related to the management of nutrition in ICU patients suffering from COVID-19. Therefore, a positive effect is expected to be seen in the study of the market by COVID-19.

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005